Medical Exoskeleton Market Size, Share, Growth Analysis, By Component (Software, Service, Hardware), By Type (Powered, Passive), By Extremity (Lower Extremity, Upper Extremity, Full Body), By Structure (Rigid Exoskeletons, Soft Exoskeletons), By Mobility (Stationary, Mobile), By Region - Industry Forecast 2024-2031

North America dominated the market with an increasing medical exoskeleton market share in 2023. This growth is due to increasing research activities expenditure, high prevalence of disabled population, rising partnerships & collaborations among key players, availability of technologically innovated products and growing public & private funding. An example would be the collaboration between Ekso Bionics, which develops exoskeleton technology to assist in care for patients with mobility issues, and U.S. Physiatry (USP) in March 2021. They joined forces to empower clinicians or physicians with knowledge of how the clinical benefits of an EksoNR exoskeleton can improve at their centers. In addition, increasing disposable income, rising geriatric population, presence of key market players at large scale, growing human augmentation in industrial and military verticals and availability of public & private investors are some other factors propelling the growth. 

The Asia Pacific medical exoskeleton market size is expected to record the highest CAGR during the forecast period, with large number of patients requiring rehabilitation assistance upturning growth. Asia Pacific region will witness the increasing efforts by key players to attract funding from various governments in order to improve and advance healthcare infrastructure. Availability of government support & funding as well as developing advanced healthcare infrastructure for a vast population is driving medical exoskeleton market growth in Asia-Pacific. This growth has also been supported by constant economic development in countries such as China, Japan and India on the back of conducive public & private support.